Chikungunya IgG/IgM Rapid Test

Chikungunya virus is spread to people by the bite of an infected mosquito. The
most common symptoms of infection are fever and joint pain. Other symptoms may
include headache, muscle pain, joint swelling, or rash. Outbreaks have occurred
in countries in Africa, Asia, Europe, and the Indian and Pacific Oceans. In
late 2013, chikungunya virus was found for the first time in the Americas on
islands in the Caribbean. There is a risk that the virus will be imported to
new areas by infected travelers. There is no vaccine to prevent or medicine to
treat chikungunya virus infection. Travelers can protect themselves by
preventing mosquito bites. When traveling to countries with chikungunya virus,
use insect repellent, wear long sleeves and pants, and stay in places with air
conditioning or that use window and door screens.


Intended Use of Chikungunya IgG/IgM Rapid Test
chikungunya antibody test is a rapid immunochromatographic assay for the
simultaneous detection of IgG and IgM antibodies to Chikungunya virus in human
whole blood, serum or plasma. The assay is used as a screening test for
Chikungunya viral infection.

Summary and Explanation of Chikungunya IgG/IgM Rapid Test
Chikungunya virus (ChikV) is a mosquito-transmitted alpha virus belonging to
the Togaviridae family, first isolated in Tanzania in 1952. Three lineages with
distinct genotypic and antigenic characteristics have been identified.
Chikungunya virus is endemic to some parts of Africa and causes recurrent
epidemic waves in Asia and the Indian subcontinent. At the end of 2013 the
virus emerged in the Americas. Human beings serve as the main chikungunya virus
reservoir during epidemic periods. In Africa, some animals constitute the virus
reservoir during non-epidemic periods sustaining virus circulation. Clinical
signs of chikungunya virus infection include sudden onset fever and severe
arthralgia (joint pain) affecting mainly the extremities but also the larger
joints. Erratic, relapsing, and incapacitating joint pain is the hallmark of
chikungunya virus. Up to 12% of patients still have chronic joint pain three
years after the onset of their illness.
Other symptoms of the infection (headache, fatigue and rash) are common among
many arborviral infections including chikungunya virus. There is no specific
therapy for chikungunya virus infection. Patients are symptomatically treated
with antiinflammatory medication. The death rate is not high, but excess
mortality has been observed occurring together with larger chikungunya virus
outbreaks. Diagnosis is based on the detection of virus by molecular methods or
by virus culture in the first days of infection before an antibody response is
evident. IgM antiChikV is detectable two to three days at the onset of symptoms
and persist for several weeks up to three months. ChikV specific IgG appears
soon after IgM antibodies and persist for years.
We provide reasonable chikungunya igg test price.
China test repid is a fast and easy-to-perform medical diagnostic test.
We also have lateral flow dispensing equipment.

Minimum Order: 100 pieces

Click to Enlarge